Home Newsfeeds IGM Biosciences Says Has Less Than $5M In Deposits At SVB

News

IGM Biosciences Says Has Less Than $5M In Deposits At SVB

-SEC Filing

byBenzinga Newsdesk

March 10, 2023

1 minute read

-SEC Filing

‘Not That Interested In Killer Robots:’ Instead, OpenAI CEO Sam Altman Is Worried ‘Subtle Misalignments’ Could Make AI Dangerous

By Rounak Jain

February 14, 8:52 AM

OpenAI CEO Sam Altman thinks we're "subtle societal misalignments" away from AI becoming dangerous and wreaking havoc.

MSFT

Oracle’s Strategic Pivot To AI And Cloud Computing Yields Market Cap Surge: Report

By Shivani Kumaresan

June 13, 12:56 PM

Oracle Corporation (NYSE: ORCL) solidified its leadership in artificial intelligence with a strategic shift to cloud computing, propelling its market capitalization nearly to $400 billion. Oracle's cloud infrastructure, pivotal for AI projects like OpenAI's expansive models, has dramatically enhanced its market valuation.

CRM

Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement

By Vandana Singh

May 3, 2:43 PM

Amneal Pharmaceuticals settles $270 million opioid crisis agreement, offering cash and naloxone spray. Boosted by strong Q1 earnings, the company reaffirms fiscal guidance.

AMRX

US Weekly Jobless Claims Likely To Increase To This Level, Here Are The Major Macro Issues For Thursday

By Lisa Levin

October 20, 2:59 AM

U.S. stocks closed lower on Wednesday with the Nasdaq Composite dropping around 90 points amid a decline in Amazon.com, Inc. (NASDAQ: AMZN) shares.

AMZN

IGM Biosciences Says Has Less Than $5M In Deposits At SVB

Related Posts

‘Not That Interested In Killer Robots:’ Instead, OpenAI CEO Sam Altman Is Worried ‘Subtle Misalignments’ Could Make AI Dangerous

Oracle’s Strategic Pivot To AI And Cloud Computing Yields Market Cap Surge: Report

Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement

US Weekly Jobless Claims Likely To Increase To This Level, Here Are The Major Macro Issues For Thursday